QuickSplint Receives Dental Industry Recognition

QuickSplint, the interim dental split, has received recognition from Dentistry Today magazine and THE DENTAL ADVISOR.

San Diego, CA (PRWEB) - Orofacial Therapeutics, LP announced today that its premier product, QuickSplint®, has received two recent industry recognitions. QuickSplint was recognized as a Reader’s Choice Top 25 First Impression Product by Dentistry Today magazine, and it was named a 2016 Clinical Problem Solver by The Dental Advisor, which reports objective clinical evaluations, product comparisons, clinical performance studies, and laboratory test results for the dental industry.

QuickSplint is an interim dental splint that can be fabricated quickly and easily in the dental practice. It is the only dental splint designed specifically for short-term use of up to 4 – 6 weeks. Uses for QuickSplint include:

• First aid for acute symptoms
• Protective and stabilizing splint
• Diagnostic aid
• Anterior bite-plane/Deprogrammer
• Transitional appliance

QuickSplint was selected as a Reader’s Choice Top 25 First Impression Product and was featured in the June 2016 issue of Dentistry Today magazine, the nation’s leading clinical news magazine. The magazine has a monthly print circulation of 140,000, and its website, dentistrytoday.com, receives an average of 90,000 visitors per month. First Impression products are generally new products that are being introduced to the dental industry for the first time. QuickSplint was selected based on reader interest among all First Impression products featured over the past year.

QuickSplint was selected as a 2016 Clinical Problem Solver by The Dental Advisor, and it was featured in the July-August 2016 Vol. 33, No. 06 of THE DENTAL ADVISOR. Clinical Problem Solvers are selected by practicing clinicians as excellent products for solving a particular clinical challenge. THE DENTAL ADVISOR has been providing relevant information to the dental profession for more than 33 years.

“When we created QuickSplint, it was our vision to help dentists and specialists address the need for diagnosing parafunctional bruxism and also to provide an immediate aid for temporary care and protection of teeth and jaw. We found that QuickSplint has many practical applications across dentistry and it is rewarding to see dentists embracing it in growing numbers,” said Ann McCulloch, president of Orofacial Therapeutics.

To learn more about QuickSplint and its uses for general dentistry, cosmetic and restorative dentistry, periodontics, endodontics, oral surgery, dental implant surgery, and more visit the QuickSplint website at http://www.quicksplint.com.

About Orofacial Therapeutics, LP
Founded by orofacial pain expert, Bradley Eli DDS, MS, Orofacial Therapeutics LP is a San Diego-based medical device company that develops a variety of aids for dentistry and orofacial pain. Dr. Eli and the company hold multiple patents in the fields of both sleep and pain. The company’s popular aid, QuickSplint, has been successfully utilized with patients for more than ten years, and became available to dentists and dental specialists in 2011. QuickSplint is FDA 510k cleared and is made in the USA. The company’s products are available for sale for use by licensed dental or medical professionals. The company accepts orders by phone, fax, online, and through a select number of dental labs and dealers. For more information, visit http://www.quicksplint.com.

QuickSplint is a registered trademark of QuickSplint LLC. Parafunction Risk Rating, Parafunction Risk Ratings, Parafunction Risk-Rating Table are copyrights of QuickSplint LLC.